LeonaBio (LONA) Accumulated Depreciation & Amortization (2020 - 2026)

LeonaBio (LONA) has 7 years of Accumulated Depreciation & Amortization data on file, last reported at $4.5 million in Q1 2026.

• Quarterly Accumulated Depreciation & Amortization rose 27.13% year-over-year to $4.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.5 million (up 27.13% YoY) and the FY2025 annual result came in at $4.3 million, up 29.5% from the prior year.
• Accumulated Depreciation & Amortization advanced to $4.5 million in Q1 2026 per LONA's latest filing, from $4.3 million in the prior quarter.
• Across five years, Accumulated Depreciation & Amortization topped out at $4.5 million in Q1 2026 and bottomed at $677000.0 in Q1 2022.
• The 5-year median for Accumulated Depreciation & Amortization is $2.6 million (2024), against an average of $2.6 million.
• The widest annual swing landed in 2022, when Accumulated Depreciation & Amortization surged 269.95%; it then advanced 27.13% in 2026.
• Tracing LONA's Accumulated Depreciation & Amortization over 5 years: stood at $1.4 million in 2022, then jumped by 70.61% to $2.3 million in 2023, then soared by 41.17% to $3.3 million in 2024, then gained by 29.5% to $4.3 million in 2025, then gained by 5.41% to $4.5 million in 2026.
• Per Business Quant, the three latest LONA Accumulated Depreciation & Amortization figures stand at $4.5 million (Q1 2026), $4.3 million (Q4 2025), and $4.0 million (Q3 2025).

Peer Comparison